2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Neoplasms
7
Uterine Cervical Neoplasms
5
Head and Neck Neoplasms
5
Prostatic Neoplasms
4
Melanoma
4
Glioblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Hematologic Neoplasms
3
Glioma
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neuroblastoma
2
Lymphedema
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Squamous Cell
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Restraint, Physical
×
Clear all
NCT02571894
2018-03-07
COBC
Karolinska University Hospital
Phase NA
Unknown
320 enrolled